Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CoFactor: Phase IIb data

In a Phase IIb trial in 300 patients, CoFactor plus 5-flourouracil missed the primary endpoint of

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE